[HTML][HTML] The metabolic fingerprint of doxorubicin-induced cardiotoxicity in male CD-1 mice fades away with time while autophagy increases
SR Brandão, A Reis-Mendes, MJ Neuparth… - Pharmaceuticals, 2023 - mdpi.com
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases
SR Brandão, A Reis-Mendes, MJ Neuparth… - …, 2023 - search.proquest.com
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases.
SR Brandão, A Reis-Mendes… - Pharmaceuticals …, 2023 - search.ebscohost.com
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases
S Brandão, A Reis-Mendes, M Neuparth… - Pharmaceuticals …, 2023 - europepmc.org
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases
SR Brandão, A Reis-Mendes… - Pharmaceuticals …, 2023 - pubmed.ncbi.nlm.nih.gov
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
[HTML][HTML] The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases
SR Brandão, A Reis-Mendes, MJ Neuparth… - …, 2023 - ncbi.nlm.nih.gov
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
The Metabolic Fingerprint of Doxorubicin-Induced Cardiotoxicity in Male CD-1 Mice Fades Away with Time While Autophagy Increases.
SR Brandão, A Reis-Mendes, MJ Neuparth… - Pharmaceuticals …, 2023 - europepmc.org
The cardiotoxicity of doxorubicin (DOX) may manifest at the beginning/during treatment or
years after, compromising patients' quality of life. We intended to study the cardiac pathways …
years after, compromising patients' quality of life. We intended to study the cardiac pathways …